Effects of sildenafil citrate on ejaculation latency, detumescence time, and refractory period: placebo-controlled, double-blind, crossover laboratory setting study
- PMID: 15708051
- DOI: 10.1016/j.urology.2004.09.012
Effects of sildenafil citrate on ejaculation latency, detumescence time, and refractory period: placebo-controlled, double-blind, crossover laboratory setting study
Abstract
Objectives: To evaluate whether sildenafil citrate (SC) prolongs ejaculation latency and detumescence time and shortens the refractory period in a laboratory setting.
Methods: Two successive double-blind, placebo-controlled, crossover laboratory studies were performed with 30 different healthy volunteers in each study (total of 60). In the first study, the subject ingested placebo or SC. Real-time penile tumescence and rigidity monitoring and audiovisual sexual stimulation was performed. When the subject had his best erection, he applied vibratory stimulation until he ejaculated, and then audiovisual sexual stimulation was stopped. Monitoring was continued until he lost rigidity. The test was repeated with the second medication in 7 to 15 days. In the second study, another group of 30 volunteers were tested, as in the first study, and audiovisual sexual stimulation was continued for an additional hour after ejaculation.
Results: In the first study, the time to ejaculation with vibratory stimulation was 2.23 and 3.89 minutes (P = 0.01) and the time to minimal tip rigidity after ejaculation was 1.93 and 3.1 minutes (P <0,001) in the placebo and SC groups, respectively. In the second study, the time to ejaculation with vibratory stimulation was 2.23 and 4.91 minutes (P = 0.006), the time to best tip rigidity after ejaculation was 19.10 and 15.66 minutes (P = 0.242), and the area under the curve of tip rigidity in 3 minutes after ejaculation was 73.61 and 144.05 (P <0.001) in the placebo and SC groups, respectively.
Conclusions: In this laboratory setting, SC seemed to prolong the ejaculation latency time. The detumescence time was also longer, with better quality. However, we did not show that SC shortens the refractory period after ejaculation.
Similar articles
-
The effects of three phosphodiesterase type 5 inhibitors on ejaculation latency time in lifelong premature ejaculators: a double-blind laboratory setting study.BJU Int. 2011 Apr;107(8):1274-7. doi: 10.1111/j.1464-410X.2010.09646.x. Epub 2010 Sep 7. BJU Int. 2011. PMID: 21929518 Clinical Trial.
-
Safety of intravenous nitroglycerin after administration of sildenafil citrate to men with coronary artery disease: a double-blind, placebo-controlled, randomized, crossover trial.Crit Care Med. 2007 Aug;35(8):1863-8. doi: 10.1097/01.CCM.0000269371.70738.30. Crit Care Med. 2007. PMID: 17522570 Clinical Trial.
-
Effect of chronic sildenafil treatment on penile endothelial function: a randomized, double-blind, placebo controlled study.J Urol. 2009 Dec;182(6):2850-5. doi: 10.1016/j.juro.2009.08.025. Epub 2009 Oct 17. J Urol. 2009. PMID: 19837434 Clinical Trial.
-
Phosphodiesterase 5 inhibitors in the treatment of premature ejaculation.Int J Androl. 2006 Oct;29(5):503-09. doi: 10.1111/j.1365-2605.2006.00689.x. Int J Androl. 2006. PMID: 16573707 Review.
-
[Medication for premature ejaculation].Zhonghua Nan Ke Xue. 2003 Jun;9(3):221-5. Zhonghua Nan Ke Xue. 2003. PMID: 12861842 Review. Chinese.
Cited by
-
Current therapeutic strategies for premature ejaculation and future perspectives.Asian J Androl. 2011 Jul;13(4):550-7. doi: 10.1038/aja.2010.130. Epub 2011 May 2. Asian J Androl. 2011. PMID: 21532601 Free PMC article. Review.
-
Tadalafil once daily in the management of erectile dysfunction: patient and partner perspectives.Patient Prefer Adherence. 2009 Nov 3;3:105-11. doi: 10.2147/ppa.s3937. Patient Prefer Adherence. 2009. PMID: 19936152 Free PMC article.
-
In vitro measurement of ejaculation latency time (ELT) and the effects of vardenafil on ELT on lifelong premature ejaculators: placebo-controlled, double-blind, cross-over laboratory setting.Int Urol Nephrol. 2010 Dec;42(4):881-7. doi: 10.1007/s11255-010-9710-2. Epub 2010 Feb 20. Int Urol Nephrol. 2010. PMID: 20174968 Clinical Trial.
-
Modeling Human Sexual Motivation in Rodents: Some Caveats.Front Behav Neurosci. 2019 Aug 27;13:187. doi: 10.3389/fnbeh.2019.00187. eCollection 2019. Front Behav Neurosci. 2019. PMID: 31507386 Free PMC article.
-
Erectile Dysfunction: Key Role of Cavernous Smooth Muscle Cells.Front Pharmacol. 2022 Jul 5;13:895044. doi: 10.3389/fphar.2022.895044. eCollection 2022. Front Pharmacol. 2022. PMID: 35865945 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources